Research Insight
WuXi AppTec Expands Site in California for Pharmaceutical R&D Services
WuXi AppTec, a leading global pharmaceutical and medical device open-access capability and technology platform company with global operations, announces the expansion of its facilities in San Diego, California. WuXi AppTec’s newly expanded facility will establish a...
Research Insight
Eisai and UCLommence preparations for phase i clinical studies in Alzheimer’s Disease for Novel Anti-Tau Antibody
Eisai Co., Ltd and University College London  announced that they have commenced preparations for Phase I clinical studies on E2814 The first clinical candidate from their drug discovery collaboration, in Alzheimer’s disease patients within fiscal 2018....
Research Insight
ADC Bio secures additional equity round investment
ADC Biotechnology , announces that it has secured additional funding of £2.5 million from existing investors and company management. The investment syndicate consists of Maven Capital Partners, Seneca Partners, the Development Bank of Wales and Downing...
Research Insight
Protagen AG collaborates with UCSF to study better immuno-profiling of cancer patients receiving immunotherapy
Protagen AG has announced the start of a collaboration with the University of California, San Francisco (UCSF) to utilize Protagen’s SeroTag® technology to investigate the immuno-profiling of prostate cancer patients treated with checkpoint inhibitors and therapeutic vaccines. ...
Articles
The Falsified Medicines Directive – are you ready?
The Falsified Medicines Directive 2011/62/EU, which is due for adoption in February 2019, will require pharmaceuticalcompanies to apply serialisation codes to every applicable pack (OTC and some minor exemptions).
As a consequence, artwork changes will be required, which all too...
Articles
Stem Cell and Regenerative Therapies for Hearing Loss
The year 2018 marks a notable milestone in the history of stem cell and regenerative medicine. It was twenty years ago, in 1998, that James Thompson and John Gearhart published methods for the creation of the first human embryonic...
Articles
High quality ophthalmic consumables at affordable prices to developing countries: An Aurolabs Case Study
Aurolab, the manufacturing division of Aravind Eye Hospital, at Madurai, Tamil Nadu that supplies high quality ophthalmic consumables at affordable prices to developing countries.
Though its primary focus is on ophthalmic industry, Aurolab is also diversifying into related health care...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read